Search for: "AstraZeneca, AB" Results 41 - 60 of 92
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 May 2015, 10:38 am
., Paul Inman and Ailsa Carter, who have summarised a decision from the Court of Appeal yesterday, AstraZeneca AB & Anor v KRKA dd Novo Mesto & Anor [2015] EWCA Civ 484. [read post]
12 Jun 2008, 4:45 am
Omeprazole is the active ingredient in Prilosec ®, which is marketed by Plaintiffs-Appellants Astrazeneca, AB, Aktiebolaget Hassle, KBI-E, Inc., KBI, Inc., and Astrazeneca LP (Astrazeneca) for the treatment of gastric and duodenal ulcers, and which acts by inhibiting the production of gastric acid. [read post]
4 May 2014, 3:14 am by Mark Summerfield
  Specifically, in AstraZeneca AB v Alphapharm Pty Ltd [2014] FCA 419, the patentee has been awarded a higher level of attorney fees under section 19 of the Patents Act, which relates to Certificates of Validity. [read post]
29 Jun 2018, 12:21 pm by Lawrence B. Ebert
(“Impax”), AstraZeneca AB, and AstraZeneca UKLimited (together, “AstraZeneca”), and entering an injunctionagainst Lannett pursuant to 35 U.S.C. [read post]
23 Mar 2012, 4:00 am by tracey
& Anor [2012] EWHC 716 (Ch) (22 March 2012) Rohl v Bickland Ltd [2012] EWHC 706 (Ch) (22 March 2012) High Court (Patents Court) Teva UK Ltd & Ors v Astrazeneca AB [2012] EWHC 655 (Pat) (22 March 2012) Regeneron Pharmacueticals Inc v Genentech Inc [2012] EWHC 657 (Pat) (22 March 2012) Source: www.bailii.org [read post]
7 Apr 2015, 11:49 am by Lawrence B. Ebert
We previously affirmedthe district court’s decision in an earlier phase of the samelitigation holding that Apotex had infringed certainpatents held by AstraZeneca AB and related parties(collectively, “Astra”). [read post]
6 Sep 2015, 12:30 am by Mark Summerfield
Last week I predicted that the High Court would affirm the finding of five judges of the Federal Court of Australia that AstraZenenca’s patents covering low-dosage forms of the cholesterol-lowering drug marketed as CRESTOR (having the active ingredient rosuvastatin) are invalid on grounds of obviousness.In the much-anticipated decision in AstraZeneca AB v Apotex Pty Ltd (et al) [2015] HCA 30, five judges of the High Court, in four distinct concurring opinions, have… [read post]
17 May 2015, 6:28 am by Mark Summerfield
  3M, however, lives on in the continuing failure of all attempts at legislative correction to produce laws consistent with the approach taken in the rest of the developed world.In the latest chapter of this ongoing saga, on the 13th and 14th of May the Australian High Court heard oral arguments in the appeal by pharmaceutical company AstraZeneca AB against last year’s ruling of an expanded five-judge Full Bench of the Federal Court of Australia that its two patents… [read post]
8 Dec 2021, 8:47 am by Dennis Crouch
by Dennis Crouch Astrazeneca AB v. [read post]
20 Apr 2012, 10:36 am by Sheppard Mullin
Plaintiffs/Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca AB, IPR Pharmaceuticals, Inc., and The Brigham and Women’s Hospital, Inc. [read post]
14 Mar 2011, 9:50 am by Dennis Crouch
Philips 74 14 Mag Instrument 70 15 Merck 69 16 3M Innovative Properties Company 67 17 Cygnus Telecommunications Technology 64 18 Schering 64 19 Millennium 63 20 Eli Lilly And Company 61 21 Promote Innovation (False Marking) 60 22 Melvino Technologies 59 23 Teva Pharmaceuticals 58 24 AstraZeneca AB 54 25 Eon-Net 54     Rank Patent Plaintiff Number of Defendants Non-Practicing Entity 1 Ronald A Katz Technology… [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
Aquatron Inc. and Aqua Group LLC (patent infringement) 1/7: AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited and AstraZeneca AB v. [read post]
5 Jan 2011, 1:34 am by Kelly
General AUTM’s 2010 Better World Report highlights (PatentlyBIOtech) Drug R&D advocate named Kenyan ambassador to UN Geneva (IP Watch) US: Patent eligibility and In re Grams (Patent Docs) US: Main Hastings files false marking complaint against Pfizer based on products from its animal health division (Patent Docs) US: IDEXX files patent infringement complaint against Abbott Laboratories based on its sale of Architect HIV Ag/Ab Combo assay (Patent Docs) US: Life Technologies files… [read post]
20 Nov 2012, 7:50 am
* On Thursday 6 December, judgment will be given in Case C‑457/10 P AstraZeneca AB and Astra Zeneca plc v European Commission. [read post]